Absence of telomerase activity and telomerase catalytic subunit mRNA in melanocyte cultures

被引:8
作者
Dhaene, K
Vancoillie, G
Lambert, J
Naeyaert, JM
Van Marck, E
机构
[1] Univ Instelling Antwerp, Pathol Lab, Dept Med, B-2610 Wilrijk, Belgium
[2] State Univ Ghent Hosp, Dept Dermatol, B-9000 Ghent, Belgium
关键词
telomerase; melanoma; hTERT; proliferation; Ki-S2; Ki-S5;
D O I
10.1054/bjoc.1999.1041
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The classic model of activation of telomerase, for which activity has been found in most cancers including cutaneous malignant melanoma (CMM), dictates that enzyme activity is generated by pathological reactivation of telomerase in telomerase-negative somatic cells. However, recent data demonstrated physiological up-regulation in some normal cell types when established as proliferating cultures, indicating that, in some cancer types, telomerase is expressed by the process of up-regulation in telomerase-competent precursor cells. In this study, cultures of epidermal melanocytes, progenitor cells of CMM, were established and harvested in the logarithmic phase of growth. Telomerase activity was looked for using a non-isotopic variant of the telomeric repeat amplification protocol, and transcript expression of the hTERT gene, the rate-limiting catalytic telomerase subunit, was investigated by the reverse transcription polymerase chain reaction. Neither telomerase activity nor hTERT mRNA could be detected in proliferating melanocyte cultures. Our in vitro data argue against the model of telomerase as a common biomarker of cell proliferation. The results further suggest that telomerase is tightly controlled in normal melanocytes, and that telomerase is reactivated rather than up-regulated in melanocytic precursors during melanoma initiation or progression. (C) 2000 Cancer Research Campaign.
引用
收藏
页码:1051 / 1057
页数:7
相关论文
共 60 条
  • [2] Albino Anthony P., 1995, Current Opinion in Oncology, V7, P162, DOI 10.1097/00001622-199503000-00012
  • [3] TELOMERE SHORTENING IS ASSOCIATED WITH CELL-DIVISION IN-VITRO AND IN-VIVO
    ALLSOPP, RC
    CHANG, E
    KASHEFIAAZAM, M
    ROGAEV, EI
    PIATYSZEK, MA
    SHAY, JW
    HARLEY, CB
    [J]. EXPERIMENTAL CELL RESEARCH, 1995, 220 (01) : 194 - 200
  • [4] Activation of telomerase and its association with G1-phase of the cell cycle during UVB-induced skin tumorigenesis in SKH-1 hairless mouse
    Balasubramanian, S
    Kim, KH
    Ahmad, N
    Mukhtar, H
    [J]. ONCOGENE, 1999, 18 (06) : 1297 - 1302
  • [5] Telomerase activity: A biomarker of cell proliferation, not malignant transformation
    Belair, CD
    Yeager, TR
    Lopez, PM
    Reznikoff, CA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) : 13677 - 13682
  • [6] Bosserhoff AK, 1997, BIOCHEMICA, V3, P16
  • [7] EPIDEMIOLOGY OF MALIGNANT-MELANOMA
    BOYLE, P
    MAISONNEUVE, P
    DORE, JF
    [J]. BRITISH MEDICAL BULLETIN, 1995, 51 (03) : 523 - 547
  • [8] MELANOMA PRECURSOR LESIONS AND BORDERLINE MELANOMAS
    BRIGGS, JC
    [J]. HISTOPATHOLOGY, 1985, 9 (12) : 1251 - 1262
  • [9] The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter
    Cong, YS
    Wen, JP
    Bacchetti, S
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (01) : 137 - 142
  • [10] TELOMERASE ACTIVITY IN NORMAL LEUKOCYTES AND IN HEMATOLOGIC MALIGNANCIES
    COUNTER, CM
    GUPTA, J
    HARLEY, CB
    LEBER, B
    BACCHETTI, S
    [J]. BLOOD, 1995, 85 (09) : 2315 - 2320